ICON plc (ICLR)
NASDAQ
Closed
Aug 24, 2026
Day's Range
168.3852 wk Range
66.57Overview - ICLR - ICON plc
Key Statistics
Valuation
Enterprise Value
15.88B
P/E (Trailing)
‪264.96‬
P/E (Forward)
‪14.50‬
PEG Ratio
‪-4.46‬
Price / Sales (TTM)
‪1.60‬
Price / Book
‪1.41‬
EV / EBITDA
‪30.34‬
Profitability
Gross Margin
‪23.22%‬
Profit Margin
‪0.32%‬
Operating Margin
‪9.41%‬
Return on Assets
‪0.96%‬
Return on Equity
‪0.28%‬
Ownership
Shares Outstanding
77.15M
Float
77.09M
Short % of Shares Outstanding
‪3.26%‬
Held by Insiders
‪0.44%‬
Held by Institutions
‪108.36%‬
Price stats
Beta
‪1.20‬
50-Day Avg
‪164.27‬
200-Day Avg
‪147.14‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
17 analysts
Average price target
‪$ 185.56‬Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - ICLR - ICON plc
Peers - ICLR - ICON plc
Peer Comparison
Compared with companies in Diagnostics & Research listed on NASDAQ.
- ICICLRNASDAQICON plc13.28BMarket Cap+0.28%52-week change272.41P/E (Trailing)‪0.32%‬Profit Margin
- NTRANASDAQNATERA INC (Common Stock) – ticker 45E47.86BMarket Cap+51.07%52-week change-218.44P/E (Trailing)‪-7.10%‬Profit Margin
- IDXXNASDAQIDEXX Laboratories, Inc.43.87BMarket Cap-15.16%52-week change39.53P/E (Trailing)‪25.03%‬Profit Margin
- ILMNNASDAQIllumina, Inc.33.12BMarket Cap+54.58%52-week change41.01P/E (Trailing)‪18.33%‬Profit Margin
- GHNASDAQGuardant Health Inc.22.90BMarket Cap+63.75%52-week change-51.42P/E (Trailing)‪-38.32%‬Profit Margin
- MEDPNASDAQMedpace Holdings Inc.17.32BMarket Cap+24.80%52-week change35.96P/E (Trailing)‪17.66%‬Profit Margin
- RDNTNASDAQRadNet Inc.6.04BMarket Cap+9.41%52-week change1425.75P/E (Trailing)‪-0.93%‬Profit Margin
Profile Summary - ICLR - ICON plc
About
ICON plc is a leading global contract research organization (CRO) that provides outsourced drug and device development and commercialization services to pharmaceutical, biotechnology, medical device, and government organizations. It specializes in full-service clinical trials from Phase I to IV, including complex…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
